Barbara Silvestri

492 total citations
18 papers, 296 citations indexed

About

Barbara Silvestri is a scholar working on Oncology, Immunology and Biotechnology. According to data from OpenAlex, Barbara Silvestri has authored 18 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 4 papers in Biotechnology. Recurrent topics in Barbara Silvestri's work include Microbial Inactivation Methods (4 papers), Cutaneous Melanoma Detection and Management (4 papers) and Immunotherapy and Immune Responses (3 papers). Barbara Silvestri is often cited by papers focused on Microbial Inactivation Methods (4 papers), Cutaneous Melanoma Detection and Management (4 papers) and Immunotherapy and Immune Responses (3 papers). Barbara Silvestri collaborates with scholars based in Italy, Germany and United Kingdom. Barbara Silvestri's co-authors include G. Lagalla, Anna Campanati, Rosaria Gesuita, Annamaria Offidani, Paola Del Bianco, R. A. De Blasi, Stefano Palmisani, Luigi Chieco‐Bianchi, Domenico Massullo and Antonio D’Andrilli and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Physical Therapy.

In The Last Decade

Barbara Silvestri

17 papers receiving 282 citations

Peers

Countries citing papers authored by Barbara Silvestri

Since Specialization

Citations

This map shows the geographic impact of Barbara Silvestri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Silvestri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Silvestri more than expected).

Fields of papers citing papers by Barbara Silvestri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Silvestri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Silvestri. The network helps show where Barbara Silvestri may publish in the future.

Co-authorship network of co-authors of Barbara Silvestri

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Silvestri. A scholar is included among the top collaborators of Barbara Silvestri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Silvestri. Barbara Silvestri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Prospective multicentre study of patients with cutaneous metastases from breast cancer treated with electrochemotherapy 2025 ·Clinical & Experimental Metastasis ·(unknown), Giacomo Corrado, (unknown), Emilia Migliano, Raimondo Di Giacomo, (unknown), Claudio Zamagni, Ada Ala, L Campana, (unknown), Matteo Ghilli, (unknown), (unknown), (unknown), (unknown), Barbara Silvestri, Maria Vittoria Dieci, Valentina Guarneri, Marco Rastrelli	0
2	Electrochemotherapy (ECT) in treatment of mucosal head and neck tumors. An international network for sharing practices on ECT (InspECT) study group report 2024 ·European Journal of Surgical Oncology ·Giulia Bertino, (unknown), (unknown), (unknown), Barbara Silvestri, (unknown), Paolo Matteucci, Giuseppe Riva, (unknown), (unknown), (unknown), Tobian Muir, Christian Kunte, (unknown), Gregor Serša	3
3	Electrochemotherapy as adjuvant treatment in a sinonasal mucosal melanoma in elderly patient: a case report 2024 ·European Archives of Oto-Rhino-Laryngology ·(unknown), Barbara Silvestri, (unknown), Enrico Armato, (unknown), (unknown), Francesca de Terlizzi, Giuseppe Azzarello	2
4	Efficacy of Electrochemotherapy in Breast Cancer Patients of Different Receptor Status: The INSPECT Experience 2023 ·Cancers ·(unknown), Matteo Mascherini, Alastair D. MacKenzie Ross, Barbara Silvestri, Erika Kis, Joy Odili, (unknown), (unknown), Christian Kunte, Antonio Orlando, A. James P. Clover, (unknown), (unknown), Paolo Matteucci, Tobian Muir, Francesca de Terlizzi, Julie Gehl, Eva‐Maria Grischke	5
5	Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion: a double-blind, randomized, active-controlled trial 2017 ·British Journal of Anaesthesia ·Marco Mercieri, Stefano Palmisani, R. A. De Blasi, Antonio D’Andrilli, Alessia Naccarato, Barbara Silvestri, (unknown), Domenico Massullo, Monica Rocco, Roberto Arcioni	26
6	O065. Drug-resistant chronic cluster headache successfully treated with supraorbital plus occipital nerve stimulation. A rare case report 2015 ·The Journal of Headache and Pain ·Marco Mercieri, Andrea Negro, Barbara Silvestri, (unknown), (unknown), Roberto Arcioni, Paolo Martelletti	2
7	Intermittent intensified high-dose intravenous interferon alpha 2b (IFNa2b) for adjuvant treatment of stage III malignant melanoma: Pooled analysis of two randomized phase III trials (NCT00226408 and ISRCTN75125874) with 980 patients. 2013 ·Journal of Clinical Oncology ·Michael Weichenthal, Vanna Chiarion‐Sileni, Axel Hauschild, Paola Del Bianco, Uwe Trefzer, Michele Guida, Alexander Enk, Antonella Romanini, Carmen Loquai, Ruggero Ridolfi, Dirk Schadendorf, Mario Mandalà, Josef Koller, Barbara Silvestri, Helen Gogas, (unknown), Reinhard Dummer, Gian Luca De Salvo, Peter Mohr	1
8	Intensified high-dose intravenous interferon alpha 2b (IFNa2b) for adjuvant treatment of stage III melanoma: A randomized phase III Italian Melanoma Intergroup (IMI) trial [ISRCTN75125874]. 2011 ·Journal of Clinical Oncology ·Vanna Chiarion‐Sileni, Michele Guida, Antonella Romanini, Ruggero Ridolfi, Mario Mandalà, Paola Del Bianco, Barbara Silvestri, Marco Medici, Maria Michiara, Maurizia Dalla Palma, (unknown), Jacopo Pigozzo, Francesco Laveder, Gian Luca De Salvo, (unknown)	15
9	Oxycodone Controlled-Release as??First-Choice Therapy for Moderate-to-Severe Cancer Pain in??Italian Patients 2008 ·Clinical Drug Investigation ·Barbara Silvestri, Elena Bandieri, Salvatore Del Prete, Giovanni Pietro Ianniello, (unknown), (unknown), Giovanni Sabbatini, (unknown), Alessandro Marra, Enrico Aitini, (unknown), Ferdinando Garetto, Giuseppe Nastasi, Francovito Piantedosi, (unknown), (unknown)	22
10	Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI – Mel.A.) [ISRCTN75125874] 2006 ·BMC Cancer ·Vanna Chiarion‐Sileni, Paola Del Bianco, Antonella Romanini, Michele Guida, Adriano Paccagnella, (unknown), Emanuele Naglieri, Ruggero Ridolfi, Barbara Silvestri, Maria Michiara, Gian Luca De Salvo	18
11	Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer 2005 ·(unknown), (unknown), Giuseppe Azzarello, Giovanni Pappagallo, Donata Sartori, A. Iop, (unknown), Francesco Rosetti, Barbara Silvestri, Salvatore Bonura, (unknown), Orazio Vinante	5
12	Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: Results of an open-label study 2003 ·Clinical Therapeutics ·Anna Campanati, (unknown), (unknown), (unknown), Barbara Silvestri, G. Lagalla, Rosaria Gesuita, Annamaria Offidani	87
13	Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients 2001 ·Diabetes Research and Clinical Practice ·Daniela Bruttomesso, (unknown), Barbara Silvestri, (unknown), Maria Cristina Marescotti, Elisabetta Iori, Anna Valerio, (unknown), A. Pianta, Antonio Tiengo, Stefano Del Prato	9
14	Lymphoproliferative Disease in Human Peripheral Blood Mononuclear Cell-Injected SCID Mice. IV. Differential Activation of Human Th1 and Th2 Lymphocytes and Influence of the Atopic Status on Lymphoma Development 1998 ·The Journal of Immunology ·Vincenzo Coppola, Arianna Veronesi, Stefano Indraccolo, Francesca Calderazzo, Marta Mion, Sonia Minuzzo, Giovanni Esposito, Daniele Mauro, Barbara Silvestri, Paolo Gallo, P. Falagiani, Alberto Amadori, Luigi Chieco‐Bianchi	15
15	Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family 1998 ·Clinical & Experimental Immunology ·Barbara Silvestri, Francesca Calderazzo, Vincenzo Coppola, Antonio Rosato, Stefano Iacobelli, Clara Natoli, A. Ullrich, I Sures, (unknown), (unknown), Luigi Chieco‐Bianchi, A. Amadori	21
16	Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII) 1992 ·Diabetes Research and Clinical Practice ·Daniela Bruttomesso, (unknown), (unknown), (unknown), Barbara Silvestri, (unknown), Antonio Tiengo, Stefano Del Prato	2
17	Activity, Recovery, Growth: The Communal Role of Planned Activities 1977 ·Physical Therapy ·Barbara Silvestri	5
18	Physiology of Respiration 2nd ed 1975 ·Physical Therapy ·Barbara Silvestri	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact